BioTek Instruments, Inc., is a global leader in the development, manufacture and sale of microplate instrumentation and software. Servicing customers across the world requires rapid responses and ...
Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis BioTek is a recognized leader for plate ...
Since the onset of the current pandemic, COVID-19 has been described largely as a respiratory disease. While the respiratory tract and alveoli are one of the primary sites of infection and pathology, ...
BioTek Instruments is pleased to announce its collaboration with MilliporeSigma on an integrated solution for long-term live cell experiments and dynamic time-lapse analyses, including automated cell ...
Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window) ...
BioTek Instruments announces enhancements to the MultiFlo™ FX Multi-Mode Dispenser to facilitate cell biology workflows. MultiFlo FX has a modular design that makes it easy for users to add ...
BioTek Instruments, Inc., a part of Agilent, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation, announced the launch of new Quantitative ...
Agilent Technologies has agreed to acquire BioTek Instruments for a net price after tax benefits of about $1.05 billion. Based in Winooski, Vermont, BioTek produces cell-imaging systems, microplate ...
September 6, 2017, WINOOSKI VT, USA — BioTek proudly announces its donation of $25,000 towards the construction of the Science, Technology, Engineering and Mathematics (STEM) Complex at The University ...
Agilent A will acquire BioTek Instruments in a $1.165 billion deal. The transaction is expected to be completed in Agilent’s fiscal fourth quarter. BioTek designs, manufactures and distributes life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results